Hepatoprotective Role of Endogenous Interleukin-13 in a Murine Model of Acetaminophen-Induced Liver Disease
详细信息    查看全文
文摘
Recent evidence suggests that a deficiency in one or more hepatoprotective regulatory mechanismsmay contribute to determining susceptibility in drug-induced liver disease. In the present study, weinvestigated the role of interleukin (IL)-13 in acetaminophen (APAP)-induced liver disease (AILD).Following APAP (200 mg/kg) administration to male C57BL/6 wild-type (WT) mice, hepatotoxicitydeveloped up to 24 h post-APAP, with a concomitant increase in serum IL-13 concentration. Pretreatmentof these mice with an IL-13-neutralizing antibody exacerbated liver injury, as did APAP administrationto IL-13 knockout (KO) mice in comparison to WT mice. No difference was observed in either overallAPAP-protein adduct formation or liver glutathione levels between KO and WT mice following APAPadministration, suggesting that the increased susceptibility of IL-13 KO mice to AILD was not due toenhanced APAP bioactivation but rather injurious downstream events. In this regard, multiplex antibodyarrays were used to identify potential IL-13-regulated biomarkers, including various cytokines andchemokines, as well as nitric oxide (NO), associated with AILD that were present at higher concentrationsin the sera of APAP-treated IL-13 KO mice than in WT mice. Subsequent inhibition studies determinedinterferon-rs/gamma.gif" BORDER=0 >, NO, neutrophils, natural killer cells, and natural killer cells with T-cell receptors hadpathologic roles in AILD in IL-13 KO mice. Taken together, these results suggest that IL-13 is a criticalhepatoprotective factor modulating the susceptibility to AILD and may provide hepatoprotection, in part,by down-regulating protoxicant factors and cells associated with the innate immune system.

© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号

地址:北京市海淀区学院路29号 邮编:100083

电话:办公室:(+86 10)66554848;文献借阅、咨询服务、科技查新:66554700